Wegovy — Class II drug recall D-0245-2026
Ongoing recall by Novo Nordisk Inc., reported 2026-01-07, distributed nationwide. Presence of Particulate Matter: Hair was found in a prefilled syringe
| Recall number | D-0245-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Novo Nordisk Inc., Plainsboro, NJ, United States |
| Recall initiated | 2025-12-19 |
| Classified | 2025-12-31 |
| Reported by FDA | 2026-01-07 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 00169-4501-14 |
| Lot numbers | RZFYA53, RZFYK06 |
| Expiration dates | 2027-03-31 |
Product
Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14
Reason for recall
Presence of Particulate Matter: Hair was found in a prefilled syringe
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0245-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.